SRE Holdings subsidiary Medix declares JPY600.6m dividend

SRE Holdings Corporation announced today, September 16, 2025, that its 100% consolidated subsidiary, Medix Corporation, has resolved to distribute a dividend of surplus to SRE Holdings. The total dividend amount is JPY600,600,000, with an effective date of September 19, 2025.

Regarding the impact on SRE Holdings' financial results, the company will recognize this received dividend as non-operating income in its individual financial statements for the fiscal year ending March 2026. This intercompany dividend from a consolidated subsidiary will not have an impact on SRE Holdings' consolidated financial results for the fiscal year ending March 2026.

The announcement was made by SRE Holdings Corporation, with representative director, president, and chief executive Kazuyoshi Nishiyama, and executive officer and head of planning and management department Toru Matsui. SRE Holdings is listed on the Prime Market of the Tokyo Stock Exchange.